Mustafa Özgüroğlu - Professor of Medical Oncology - Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine | LinkedIn
![How to get to Sagaza Madrid Wedding Dress and Evening Dress in Nişantaşı, Şişli by Bus, Metro or Cable Car? How to get to Sagaza Madrid Wedding Dress and Evening Dress in Nişantaşı, Şişli by Bus, Metro or Cable Car?](https://appassets.mvtdev.com/map/41/s/1563/21471537.jpg)
How to get to Sagaza Madrid Wedding Dress and Evening Dress in Nişantaşı, Şişli by Bus, Metro or Cable Car?
![Türkiye Klinikleri Tıbbi Onkoloji - Özel Konular 2010 - Cilt 3 Sayı 3 | Dergiler | Türkiye Klinikleri Türkiye Klinikleri Tıbbi Onkoloji - Özel Konular 2010 - Cilt 3 Sayı 3 | Dergiler | Türkiye Klinikleri](https://www.turkiyeklinikleri.com/upload/issuecover/tibbionkolojiozel3-3-10kapak.jpg)
Türkiye Klinikleri Tıbbi Onkoloji - Özel Konular 2010 - Cilt 3 Sayı 3 | Dergiler | Türkiye Klinikleri
Mustafa Özgüroğlu - Professor of Medical Oncology - Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine | LinkedIn
Title of the study: Phase II Clinical Study Evaluating the Efficacy and Safety of Weekly Docetaxel and Four Weekly Carboplat
Mustafa Özgüroğlu - Professor of Medical Oncology - Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine | LinkedIn
![Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit | Research profile Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit | Research profile](https://www.researchgate.net/publication/351409175/figure/tbl2/AS:1024793168064519@1621341139945/Treatment-emergent-Adverse-Events-Any-Grade-in-10-of-Total-Population-Related-to_Q320.jpg)
Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit | Research profile
![Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO) - Lung Cancer Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO) - Lung Cancer](https://www.lungcancerjournal.info/cms/asset/41a9cefe-73ec-4bcd-998b-5bcf28f86c98/gr2.jpg)
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO) - Lung Cancer
Mustafa Özgüroğlu - Professor of Medical Oncology - Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine | LinkedIn
![Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit | Research profile Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit | Research profile](https://i1.rgstatic.net/ii/profile.image/359041135071232-1462613485394_Q512/Mustafa-Oezgueroglu.jpg)